With greater understanding of resistance growth and enhancements in tolerability and potency of antiretroviral agents, altering therapy in individuals with virologic suppression is becoming a far more widespread practice. Some Major good reasons for routine improve incorporate [8] :The FDA permitted in 2021 rilpivirine IM and cabotegravir IM as a w… Read More